Clinical Importance of Estrogen Receptor-β Evaluation in Breast Cancer Patients Treated With Adjuvant Tamoxifen Therapy
2008 · Journal of Clinical Oncology · 232 citations
https://doi.org/10.1200/jco.2007.14.2968
N
Naoko Honma
Toho University(JP)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
122
Papers
2.6K
Citations
28
h-index
57
i10-index
Naoko Honma is an academic researcher from Toho University. The author has contributed to research in topics: Breast Cancer Treatment Studies & Estrogen and related hormone effects & Breast Lesions and Carcinomas. The author has an h-index of 28, co-authored 104 publications.
ORCID: 0000-0002-0400-0791Papers by this author
worksDifferences in clinical importance of Bcl-2 in breast cancer according to hormone receptors status or adjuvant endocrine therapy
2015 · BMC Cancer · 65 citations
https://doi.org/10.1186/s12885-015-1686-y
Proportion of estrogen or progesterone receptor expressing cells in breast cancers and response to endocrine therapy
2014 · The Breast · 47 citations
https://doi.org/10.1016/j.breast.2014.08.003
Ki-67 evaluation at the hottest spot predicts clinical outcome of patients with hormone receptor-positive/HER2-negative breast cancer treated with adjuvant tamoxifen monotherapy
2013 · Breast Cancer · 39 citations
https://doi.org/10.1007/s12282-013-0455-5
Assessment of the Ki67 labeling index: a Japanese validation ring study
2014 · Breast Cancer · 22 citations
https://doi.org/10.1007/s12282-014-0536-0
Clinicopathological characteristics, practical treatments, prognosis, and clinical issues of older breast cancer patients in Japan
2020 · Breast Cancer · 19 citations
https://doi.org/10.1007/s12282-020-01188-8
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat